Unleashing the potential of genomics to transform human health and the world we live in

Our mission

Our mission is to transform human health and the world we live in by developing innovative technologies that unleash the potential of genomics.

HubSpot Video

The problem: noise

Genomic analysis remains slow and complex, with only a tiny fraction of genomic data providing useful insights. Identifying this information is equivalent to finding a needle in an enormous haystack, requiring complex and costly bioinformatics.

HubSpot Video

Biofidelity's solution: reduce the noise

Our revolutionary technology fundamentally changes the way genomic analysis is conducted. By eliminating uninformative DNA, our products massively reduce the time, cost, and complexity of genomic analysis, improving accuracy and enabling faster and simpler decision-making.

Biofidelity – accelerating the genomics revolution.

HubSpot Video

Our team

Barnaby Balmforth

Chief Executive Officer

Stephen Miller

Chief Commercial Officer

Wendy J. Levin, MD, MS

Chief Medical Officer

Robert Osborne

Chief Operating Officer

Clare Hammond

Director of People

Heiner Dreismann


Barnaby Balmforth

Chief Executive Officer

Cameron Frayling


Ciarán O’Leary


Matthew Frohn


Matt Franklin


Mace Rothenberg, MD

Hesham A. Abdullah, MD, MS

Jerald Radich, MD

Lee Newcomer, MD


Introducing ASPYRE-Lung

By simplifying the detection of genomic biomarkers from either tissue or blood, use of ASPYRE-Lung as a first-line diagnostic helps identify those patients who will likely benefit from precision medicine in a fraction of the time and cost of NGS.

Contact us

Be a part of something life changing

If you have the skills, energy and innovation to help deliver our strategy, we want to hear from you.